Pure Global AI
Manufacturer profile

SIEMENS AUDIOLOGISCHE TECHNIK GMBH; INTERACOUSTICS A/S

TaiwanGermany;;Denmark2 products registeredOct 18, 2012 – Mar 27, 2013
VerifiedTFDA · Taiwan Food and Drug Administration registry
2
Total products
2
Product types
0
Active products
Mar 2013
Latest registration
Company details
Address
GEBBERTSTRBE, 125. 91058 ERLANGEN, GERMANY;;DREJERVANGET 8, DK-5610 ASSENS, DENMARK
Regulatory footprint
Search SIEMENS AUDIOLOGISCHE TECHNIK GMBH; INTERACOUSTICS A/S across other regulatory registries
ThailandEuropean UnionColombiaSouth KoreaCanadaEcuador
Recent registrations
Latest 5 products registered by this manufacturer
"Siemens" hearing aid analysis system
Class 2
Mar 27, 2013
"Siemens" audiogram (unsterilized)
Class 1
Oct 18, 2012
Most popular products
Products with most registrations
"Siemens" hearing aid analysis system
1 registrations
"Siemens" audiogram (unsterilized)
1 registrations
Authorized representatives
Taiwan authorized representatives for this manufacturer
SIEMENS LIMITED
2 products
Recent registered products
Most recent products (showing top 20)
"Siemens" hearing aid analysis system
Registered: Mar 27, 2013 • Expires: Mar 27, 2018
Cancelled
Risk Class
Class 2
AR
SIEMENS LIMITED
"Siemens" audiogram (unsterilized)
Registered: Oct 18, 2012 • Expires: Oct 18, 2017
Cancelled
Risk Class
Class 1
AR
SIEMENS LIMITED
About this profile

Explore comprehensive manufacturer profile for SIEMENS AUDIOLOGISCHE TECHNIK GMBH; INTERACOUSTICS A/S based in Germany;;Denmark through Pure Global AI's free Taiwan medical device database. This manufacturer has 2 products registered in Taiwan across 2 unique product categories. Their regulatory history spans from Oct 18, 2012 to Mar 27, 2013.

This page provides detailed insights including 2 recent product registrations, 2 most popular products with "Siemens" hearing aid analysis system having 1 registrations, and 1 authorized representatives including SIEMENS LIMITED. Pure Global AI offers free access to Taiwan's medical device database, enabling global MedTech companies to analyze market dynamics and identify opportunities.